JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

New test offers better insight into genetic risk of type 1 diabetes in people of African descent

Recently, a team of researchers in the United States developed a test to identify individuals of African descent who are more likely to get the diseas...

Read More

JDRF Canada welcomes new Chief Scientific Officer, Dr. Sarah Linklater

JDRF Canada welcomes new Chief Scientific Officer, Dr. Sarah Linklater

We are pleased to announce Dr. Sarah Linklater has been appointed as Chief Scientific Officer (CSO). 


Studying the role of Vitamin D in the risk of type 1 diabetes

Studying the role of Vitamin D in the risk of type 1 diabetes

Does Vitamin D play a role in developing type 1 diabetes (T1D)?


Sernova recruits first subjects for its Cell Pouch<sup>TM</sup> diabetes clinical trial

Sernova recruits first subjects for its Cell Pouch diabetes clinical trial

Since 2016, JDRF and Sernova Corp., a clinical-stage regenerative medicine company, have been collaborating on innovative technology to treat hypoglycaemia (low sugar) unawareness in patients with severe T1D.


Drug approved for treatment of psoriasis and Crohn's disease may protect beta cell transplants

Drug approved for treatment of psoriasis and Crohn's disease may protect beta cell transplants

Currently, JDRF-funded researcher, Dr. Jan Dutz, and his team at the University of British Columbia are investigating whether the administration of an antibody called ustekinumab among adults and children newly diagnosed with T1D can protect insulin-producing beta cells.


Exploring oral therapy to safeguard beta cells and treat type 1 diabetes

Exploring oral therapy to safeguard beta cells and treat type 1 diabetes

Administering insulin on a daily basis can be a tedious task, particularly among individuals newly diagnosed with type 1 diabetes (T1D). To mitigate this, researchers are currently experimenting with islet (insulin-producing cells) transplantation as a promising therapy that eliminates the need for ...


#AccessForAll: We're demanding affordable and accessible coverage for everyone living with type 1 diabetes

#AccessForAll: We're demanding affordable and accessible coverage for everyone living with type 1 diabetes

JDRF is excited to be launching our new Access for All campaign this week to urge provincial and territorial governments, insurers and employers to help make life-changing technologies affordable and accessible for Canadians with type 1 diabetes.


Ontario teens develop innovative survival kit for people with diabetes

Ontario teens develop innovative survival kit for people with diabetes

For most people, a power failure is a huge inconvenience. However, for someone living with type 1 diabetes (T1D), it can be a daunting – and potentially fatal – experience since their insulin needs to be kept refrigerated.


An insulin pill for type 1 diabetes

An insulin pill for type 1 diabetes

Administering multiple insulin injections is one of the many daily burdens for people living with type 1 diabetes (T1D) – particularly among those with a needle phobia. However, a team of scientists is hoping to change all that with the development of an insulin pill to manage the condition.


JDRF Collaborates to Support Diabetes 360⁰ Initiative

JDRF Collaborates to Support Diabetes 360⁰ Initiative

Diabetes 360⁰ is a framework for a pan-Canadian diabetes strategy aimed at drastically reducing and eventually ending diabetes 


Lets turn type one into type none